Accelerated Aging, HIV Infection, Antiretroviral Therapies
NCT01038999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2012-12-27
Summary
The main goal is to confirm, among HIV1-infected patients, data from in vitro studies showing that antiretroviral therapies induce an accelerated aging through the same mechanisms than genetic laminopathies or than "physiological " aging, that is through the synthesis and persistence of farnesylated prelamin A. The secondary goal is to measure the impact of HIV infection and of antiretroviral therapies on markers of cell ageing (proteasome, mitochondria, telomere). The perspective is to fix antiretroviral therapy side effects using the same drug combination that will be used in few weeks in Marseille to treat children suffering from progeria
Conditions
- HIV Infection
- Aging Accelerated
- Antiretroviral Therapies
Interventions
- BIOLOGICAL
-
Peripheral blood biological tests
A group and B group will be evaluated three times, at baseline, then every 12 months during 3 years. In case of initiation or changing of antiretroviral therapy, patients will be evaluated once more. Control subjects will be only evaluated at baseline.
Sponsors & Collaborators
-
French National Agency for Research on AIDS and Viral Hepatitis
lead OTHER_GOV
Principal Investigators
-
Isabelle POIZOT-MARTIN · CHU Sainte Marguerite -Marseille
-
Marie-Pierre DROGOUL · CHU Sainte Marguerite -Marseille
-
Olivia FAUCHER · CHU Sainte Marguerite -Marseille
-
Amélie MENARD · CHU Sainte Marguerite -Marseille
-
Joëlle MICALLEF-ROLL · CHU Timone
-
Jacques REYNES · CISIH CHRU Gui de Chauliac- Montpellier
-
Pierre DELLAMONICA · CISIH CHU Nice
-
Pierre CAU · INSERM UMR S910 MARSEILLE
-
Catherine TAMALET · Laboratoire Virologie Marseille
-
Bruno LACARELLE · Unité INSERM U911 Marseille
-
Nicolas LEVY · Laboratoire Génétique Moléculaire Marseille
-
Patrick ROLL · Laboratoire biologie cellulaire Marseille
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2010-04-30
- Completion
- 2012-03-31
Countries
- France
More Related Trials
-
A Study of the Long-Term Outcomes of HIV-Positive Patients
NCT00000932 ·Status: COMPLETED
-
Treatment of Acute HIV Infection to Preserve Immune Function
NCT00055094 ·Status: COMPLETED
-
The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk
NCT01333644 ·Status: COMPLETED
-
The Pharmacology/Aging Clinic
NCT01286623 ·Status: COMPLETED
-
HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs
NCT00007488 ·Status: COMPLETED
-
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
NCT03296202 ·Status: RECRUITING
-
Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials
NCT00183287 ·Status: COMPLETED
-
Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles
NCT02663869 ·Status: COMPLETED
-
Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs
NCT00050908 ·Status: COMPLETED
-
Microbiota Footprint and Frailty Phenotype in Virologically Suppressed People Living With HIV
NCT05078957 ·Status: RECRUITING
-
Comorbidity and Aging With HIV
NCT01466582 ·Status: ACTIVE_NOT_RECRUITING
-
Analysis of Genetic Factors Which May Influence the Course of HIV Infection
NCT00159068 ·Status: COMPLETED
-
Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older
NCT05858034 ·Status: RECRUITING ·Phase: NA
-
A Study of Immune System Activity in Healthy Adults
NCT00014053 ·Status: COMPLETED
-
Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65
NCT04321603 ·Status: WITHDRAWN ·Phase: NA
-
Long-term Follow-up of HIV Infected Patients Identified During Early Infection
NCT00086372 ·Status: COMPLETED
-
Revealing Increased Axonal Loss in Treated HIV Patients
NCT02003989 ·Status: COMPLETED
-
Evaluating Immune Function Tests in People With HIV
NCT00067795 ·Status: COMPLETED
-
HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)
NCT00043641 ·Status: COMPLETED
-
The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients
NCT00006442 ·Status: COMPLETED
-
Assessment of Age-related Hearing Loss in HIV-1 Patients
NCT02154971 ·Status: COMPLETED
-
Immune Activation in HIV-1 Infected Patients Under AntiRetroviral Treatment
NCT02334943 ·Status: COMPLETED ·Phase: NA
-
Alternative Dosing Strategy for Anti-HIV Drugs
NCT00059384 ·Status: COMPLETED ·Phase: PHASE4
-
Frailty in Older HIV-infected Individuals
NCT03413683 ·Status: RECRUITING
-
Tfh Dysfunction in HIV and Aging
NCT04487041 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4